Lung diseases
Interstitial Lung Disease (ILD) is a variety of chronic lung disorders. When a person has ILD, the lung is affected in three ways. First, the lung tissue is damaged in some known or unknown way. Second, the walls of the air sacs in the lung become inflamed. Finally, scarring (or fibrosis) begins in the interstitium (or tissue between the air sacs), and the lung becomes stiff (pulmonary fibrosis)
Several causes of pulmonary fibrosis
Occupational and environmental exposures. Many jobs - particularly those that involve mining or that expose workers to asbestos or metal dusts cause pulmonary fibrosis. Workers doing these kinds of jobs inhale small particles (like silica dusts or asbestos fibers) that can damage lungs, especially small airways and air sacs, and cause scarring (fibrosis).
Sarcoidosis : A disease characterized by formation of granulomas (areas of inflammatory cells), which attack any area of the body but most frequently affect the lungs.
Drugs : Certain medicines have the undersirable side effect of causing pulmonary fibrosis.
Radiation : Treatment for breast cancer
When all known causes of interstitial lung disease are ruled out, the condition is called "idiopathic" (of unknown origin) pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis (IPF) is a chronic disease of the lung parenchyma that leads to diffuse scarring and end-stage tissue fibrosis. Typical features in this disease include dyspnea, diffuse interstitial infiltrates, progressive lung fibrosis and poor prognosis.
The pathologic changes in IPF include patchy fibrotic lesions that vary both in age and activity and only weak inflammation. The focal zones of fibroblast proliferation are called "fibroblastic foci" and occur at sites of recent alveolar injury. The biochemical mechanisms in the pathogenesis of IPF are still poorly understood and medical therapies have thus far offered little if any benefit against progression of this disease.
Role of Noni in IPF
As the name implies, there is no known etiologic stimulus that initiates this disease. Recent evidence, including the observations that the patients with idiopathic pulmonary fibrosis have higher levels of oxidant stress than control patients, and a recent multicenter European study examining the effect of antioxidants on progression of idiopathic pulmonary fibrosis suggest that the cellular redox state plays a significant role in the progression of this disease. Current evidence suggests that both endogenous and exogenous stimuli injure the alveolar epithelium. This is followed by an abnormal repair process in individuals unable to effectively heal the damage. There are a number of studies suggesting that the cellular redox state and the balance of oxidants/ antioxidants play a significant role in the progression of pulmonary fibrosis in animal models and also possibly in human IPF.
No treatment is shown to improve prognosis of patients with this disease. The major therapeutic regimens in IPF include anti-inflammatory/ antifibrotic drugs, like corticosteroids, catatonic drugs, and IFN-.
In Idiopathic pulmonary fibrosis (IPF), deficiency of glutathione and other major antioxidants are observed in lung epithelial lining fluid (ELF). A rational therapeutic approach is to reverse the imbalance between oxidants and antioxidants in the lung by enhancing antioxidant screen. With this background, the aim of supplementing Noni in IPF is desirable. Noni contains all the antioxidant vitamins, vitamin E and vitamin C, rich with beta carotenoids. The various phyto chemicals include anthraquinone, flavonoids, Scopoletin, limonene, rutin etc. All these ingredients synergistically make Noni a powerful and effective antioxidant than all. Besides Noni also helps to secreat more endogenous anti oxidant enzymes like glutathione peroxidase, superoxide dismutase and catalase. Thus Noni may help a lot in idiopathic pulmonary fibrosis.
Regeneration of degenerative lungs tissues through Noni
Fibrotic degenerative changes occur when functional processes in lung tissues begin to breakdown. The most important inducer of this type of degeneration is the over accumulation of inorganic and organic wastes like environmental pollutants, various chemicals and drugs.
So, how do we begin regeneration ?
1. Remove poisonous waste. Noni detoxifies our cells and tissues
2. Stop or minimise their reintroduction or production with the body by effective anti oxidant quality and immune modulating property of Noni.
3. Consume raw embryonic nutrients such as those found abundantly in Noni Juice.
Recommended Dosage
Divine Noni Concentrate
5ml morning and 5ml evening for 3 days. Then
10ml morning and 10ml evening for next 3 days. Then
15ml morning and 15ml evening for next 8 months.
